Managed Account Advisors’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
$8K Buy
1,558
+10
+0.6% +$52 ﹤0.01% 2908
2015
Q1
$7K Buy
1,548
+81
+6% +$352 ﹤0.01% 2851
2014
Q4
$6K Sell
1,467
-289
-16% -$1.33K ﹤0.01% 2652
2014
Q3
$9K Buy
+1,756
New +$9.02K ﹤0.01% 2610

Other funds holding NEO

Managed Account Advisors's NEO Position: Q2 2015 in Review

Managed Account Advisors increased its NeoGenomics (NEO) stake by 0.65% in Q2 2015, buying an estimated $52 and bringing the position to 1,558 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #2908.

Managed Account Advisors first reported a position in NEO in Q3 2014 and has held it in 4 quarters since. The position peaked at $9K in Q3 2014. 97 funds tracked by Wall St. Rank hold NEO as of Q2 2015.

  • Managed Account Advisors held 1,558 shares of NeoGenomics worth $8K as of Q2 2015.
  • Managed Account Advisors bought 10 NeoGenomics shares in Q2 2015, an estimated $52.
  • NeoGenomics made up ﹤0.01% of Managed Account Advisors's portfolio in Q2 2015, its #2908 holding.
  • Managed Account Advisors first reported a position in NeoGenomics in Q3 2014 and has held it in 4 quarters since.
  • Managed Account Advisors's NeoGenomics position peaked at $9K in Q3 2014.
  • 97 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.